Daftar Pustaka 1. Weisiger, Richard MD, PhD . Isoniazid toxicity. San Fransisco: 2012. http://emedicine.medscape.com/article/180554 2. Narci C.

Teoh dan Geoffrey C. Farrell . Liver Disease Caused by Drugs. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 8th ed. 2006. California 3. Kurt J. Isselbacher, MD . Harrisons Priciples of Internal Medicine 17th edition: Toxic and Drug-Induced Hepatitis. USA: 2008 4. Thompson, NP., Caplin, ME., Hamilton MI. Anti Tuberculosis Medication and The Liver: Dangers and Recomendation in Management. European Respiratory Journal: 1995 5. Guidelines for The Management of Adverse Drug Effect of Antimycrobial Agents. Philadelphia Tuberculosis Control Program: 1998 6. Morbidity and Mortality Weekly Report. Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American horacic Society/CDC Recommendations. United States: 2001 7. Morbidity and Mortality Weekly Report . Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America. United States: 2003. 8. Pedoman Nasional Penanggulangan Tuberkulosis . Departemen Kesehatan Republik Indonesia. Jakarta: 2002. 9. Dhingra, Vk. Indian Journal Of Tuberculosis: Treatment Of Tuberculosis In Liver Disease. 2006. 10. Saukkonen, Jussi J., Cohn, David L., Jasmer, Robert M. American Thoracic Society Documents. An Official ATS Statement: Hepatotoxicity Of Antituberculosis Therapy. United States:2006. 11. Yew, Wing-wai,dr. dan Leung, Chi-chiu, dr. Antituberculosis Drugs and Hepatotoxicity. Medical Buletin. China: 2007. 12. Adhvaryu , Meghna R .dan Reddy ,Narsimha M. Prevention of hepatotoxicity due to anti tuberculosis treatment: A novel integrative approach. World Journal of Gastroenterology:2008. 13. Treatment Of Tuberculosis Guidelines 4th Edition. WHO: 2010.

14. Dhiman , Radha K., Saraswati, Vivek A., Rajekar, Harshal. A Guide To The Management Of Tuberculosis In Patients With Chronic Liver Disease. Journal Of Clinical And Experimental Hepatology. India: 2012 15. Tarjinder Sahotaa and Oscar Della Pasquaa,b Feasibility of a Fixed-Dose Regimen of Pyrazinamide and Its Impact on Systemic Drug Exposure and Liver Safety in Patients with Tuberculosis. Clinical Pharmacology Modelling & Simulation,

GlaxoSmithKline, Uxbridge, United Kingdom,a and Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden, Netherlands. 2012 16. Shanshan Wu , Yinyin Xia, Xiaozhen Lv. Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China. BMC Public Health. China: 2012 17. Rajesh Upadhyay dan Aesha Singh. Tuberculosis In Liver Cirrhosis. Medicine Update. New Delhi : 2012. 18. Price. A,Wilson. L. M. Tuberkulosis Paru. Dalam: Patofisiologi Konsep Klinis Proses-Proses Penyakit, bab 4, Edisi VI. Jakarta: EGC, 2004 : 852-64. 19. Tajiri K and Shimizu Y. Practical Guidelines for Diagnosis and Early Management of Drug-Induced Liver Injury. World J Gastroenterol 2008;14(44): 67746785 20. Roebiono PS. Tuberkulosis Merupakan Penyakit Infeksi Yang Masih Merupakan Masalah Dalam Masyarakat. Available from

http://library.usu.ac.id/download/fkm/fkm-hiswani6.pdf